Sofinnova Partners Launch $53 Million Medtech Acceleration Fund

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, May 21, 2019 at 10:32 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,979
    Likes Received:
    3
    via Sofinnova Partners, a European venture capital firm specializing in Life Sciences, announced today the launch of MD Start III, which closed above its original target of €40 million. With this new medtech acceleration fund, Sofinnova Partners continues to reinforce its coverage across the Life Sciences sector, with funds operated by dedicated teams investing from seed to late stage.

    article source